ArticleOncogene2026
YTHDC2 inhibits the resistance of lung cancer to EGFR-TKI through cuproptosis.
Jizhuang Luo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleOncogene2026
Jizhuang Luo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.